# Eikon Therapeutics, Inc. Common Stock (EIKN.US) Canonical: https://gigainvestors.com/s/EIKN Analysis as of: 2026-10-13T06:29:37.874Z. Listing currency: USD. Reporting currency: USD. ## Verdict Not enough history yet Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no. Share price: $7.54 per share; close as of 2026-10-15. ## Checklist ### understandable: na ### moat: na ### economics: na ### management: na ### accounting: na ## Holders - [Dan Davidowitz](https://gigainvestors.com/pcm): tracked 13F investor; follow the investor page for holding quarter and amounts. ## Price story Down 45% since Feb 2026 Story as of 2026-10-16T10:01:29.629Z; price observation 2026-10-15. ## Owner memo Memo as of 2026-10-16T08:06:05.509Z. ### Where the cash goes Paid no dividends in 1 year. - Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-30); Dividend observations: [[2025,0]]. Zero only counted when supported by a complete cash-flow statement. ### Are managers owners Insiders own 17.4% of the company. - Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-05); EIKN.US SharesStats.PercentInsiders = 17.377000000000002 percentage points; cache date 2026-10-05. ## Monthly share-price history (USD per share) - 2026-02: $13.78 per share - 2026-03: $10.58 per share - 2026-04: $9.62 per share - 2026-05: $10.84 per share - 2026-06: $13.05 per share - 2026-07: $9.21 per share - 2026-08: $10.46 per share - 2026-09: $8.04 per share - 2026-10: $7.54 per share ## Annual estimated value (USD per share) Historical values use today's bond yield for every fiscal year Historical values use today's FX rate into trading currency for every fiscal year Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates ## Sources [Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1861123/000119312526130395/eikn_form_10-k_2025.htm); period 2025-12-31, filed 2026-03-30. Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.
← Companies
Eikon Therapeutics, Inc. Common Stock
EIKN · US
Financial history
3 annual periods on record.
The business
- Where the cash goes
- Are managers owners
Revenue / share$0
Owner earnings / share-$6.42
Tangible book / share-$16.28